ATEC to Present at Upcoming Conferences

Rhea-AI Summary

Alphatec Holdings, Inc. (Nasdaq: ATEC) announced its participation in upcoming investor conferences and the presentation of an updated long-range financial plan. The company also disclosed the approval of inducement awards for 58 new employees in the form of restricted stock units (RSUs).

CARLSBAD, Calif.--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:

• The Canaccord Genuity Musculoskeletal Conference at the Westin St. Francis Hotel in San Francisco, CA, on February 12, 2024, at 4:00pm PT
• The Cowen Healthcare Conference at the Marriott Copley Place in Boston, MA, on March 5, 2024, at 2:10pm ET

The live webcasts will be accessible on ATEC’s Investor Relations website.

Long-Range Financial Plan Update

The Company will also present an updated long-range financial plan at the Lotte New York Palace in New York, NY, on March 19, 2024, at 3pm ET. Further detail can be found on ATEC’s Investor Relations website.

Inducement Awards Granted

As an inducement material to accepting employment with the Company, and in accordance with Nasdaq Listing Rule 5635(c)(4), ATEC today announced that the independent Compensation Committee of the Board of Directors has approved aggregate grants to 58 new employees (who are not executive officers) of, collectively, 192,482 restricted stock units (“RSUs”) under the Company’s 2016 Employment Inducement Award Plan. Of those RSUs, 178,780 will vest in equal annual installments on each of the first four anniversaries of the grant date and 13,702 will vest in equal annual installments on each of the first three anniversaries of the grant date provided, in each instance, that the recipient remains continuously employed by ATEC as of such vesting date. In addition, the RSUs will vest fully upon a change of control of ATEC.

About ATEC

ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine^TM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240129561860/en/

Investor/Media Contact:

Tina Jacobsen, CFA

Investor Relations

(760) 494-6790

investorrelations@atecspine.com

Company Contact:

J. Todd Koning

Chief Financial Officer

Alphatec Holdings, Inc.

investorrelations@atecspine.com

Source: Alphatec Holdings, Inc.

FAQ

When and where will Alphatec Holdings, Inc. participate in the Canaccord Genuity Musculoskeletal Conference?

Alphatec Holdings, Inc. will participate in the Canaccord Genuity Musculoskeletal Conference at the Westin St. Francis Hotel in San Francisco, CA, on February 12, 2024, at 4:00pm PT.

Where can the live webcasts of the investor conferences be accessed?

The live webcasts of the investor conferences will be accessible on ATEC’s Investor Relations website.

What is the purpose of the updated long-range financial plan presentation?

The purpose of the updated long-range financial plan presentation is to provide an overview of the company's financial outlook for the future.

How many new employees were granted inducement awards?

58 new employees were granted inducement awards in the form of restricted stock units (RSUs).

How many RSUs were granted and what are the vesting conditions?

A total of 192,482 RSUs were granted, with varying vesting conditions including equal annual installments and full vesting upon a change of control of ATEC.